Jorg C. Henes

Otfried Müller Str. 10,

Tuebingen, BW, DE

Expertise in

conditions

Otfried Müller Str. 10,

Tuebingen, BW, DE

OverviewLocationsClinical Research

Overview

Jorg Henes practices in Tuebingen, Germany. Henes is highly rated in 27 conditions, according to our data. Their top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Vasculitis, Bone Marrow Transplant, and Bone Graft.

Their clinical research consists of co-authoring 217 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Otfried Müller Str. 10, Tuebingen, BW 72076, Germany

Other Locations

Hoppe Seyler Str. 3, Tuebingen, BW 72076, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus

Enrollment Status: Completed

Publish Date: April 23, 2024

Intervention Type: Drug

Study Drug: LY3471851

Study Phase: Phase 2

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)

Enrollment Status: Terminated

Publish Date: May 16, 2023

Intervention Type: Drug

Study Drug: Baricitinib

Study Phase: Phase 3

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus

Enrollment Status: Terminated

Publish Date: January 30, 2023

Intervention Type: Drug

Study Drug: Baricitinib

Study Phase: Phase 3

Study Protocol for a Multi-Centre, Placebo-Controlled Phase II Study of Canakinumab for the Treatment of Adult-onset Still's Disease (AOSD) Including an Open-label Long Term Extension

Enrollment Status: Terminated

Publish Date: August 07, 2020

Intervention Type: Drug

Study Phase: Phase 2

Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis: a Prospective Non-Interventional Approach Across Europe (NISSC) for the Autoimmune Diseases Working Party of the EBMT

Enrollment Status: Completed

Publish Date: May 01, 2018

Intervention Type: Procedure

View 4 Less Clinical Trials

217 Total Publications

58-year-old patient with rheumatoid arthritis and leg edema

Journal: Deutsche medizinische Wochenschrift (1946)

Published: August 07, 2025

View All 217 Publications

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Henes's expertise for a condition

ConditionClose